Actively Recruiting
First-Line and Neoadjuvant Immunotherapy for Gastric Cancer
Led by Qilu Hospital of Shandong University · Updated on 2024-12-11
500
Participants Needed
1
Research Sites
313 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This prospective observational study aims to evaluate the efficacy and safety of immune checkpoint inhibitors as first-line and neoadjuvant therapy for advanced gastric cancer, while also investigating relevant biomarkers to better understand their role in immunotherapy outcomes
CONDITIONS
Official Title
First-Line and Neoadjuvant Immunotherapy for Gastric Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years old or above
- Diagnosed with advanced gastric cancer or locally advanced gastric cancer
- Have not received any previous anti-tumor therapy
- Planned to receive immunotherapy as first-line or neoadjuvant treatment
- Eastern Cooperative Oncology Group (ECOG) performance status of 0-1
- Adequate organ function
You will not qualify if you...
- Contraindications to immunotherapy
- Previous anti-tumor treatments including immunotherapy and chemotherapy
- History of active immune deficiency or autoimmune diseases, including HIV positive test, or other acquired/congenital immune deficiencies, or history of organ transplantation
- Severe chronic or active infection requiring systemic antibacterial, antifungal, or antiviral treatment, including tuberculosis
- History of active tuberculosis infection within 1 year before recruitment unless treatment was completed
- History of allogeneic stem cell transplantation or organ transplantation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Qilu Hospital of Shandong University
Jinan, Shandong, China, 250012
Actively Recruiting
Research Team
L
Lian Liu, MD
CONTACT
S
Song Li, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here